Moa Andresen Bergström Selected Research

Oximes

2/2009

Cutaneous metabolic activation of carvoxime, a self-activating, skin-sensitizing prohapten.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moa Andresen Bergström Research Topics

Disease

3	Hypersensitivity (Allergy) 02/2009 - 06/2006
3	Allergic Contact Dermatitis 01/2008 - 02/2005
2	Dermatitis 01/2011 - 01/2008
1	Infections 12/2023
1	Pica (Geophagia) 11/2022
1	Mental Disorders (Mental Disorder) 10/2011
1	Obesity 10/2011

Drug/Important Bio-Agent (IBA)

2	HaptensIBA 01/2008 - 02/2005
1	RNA (Ribonucleic Acid)IBA 12/2023
1	mitragynineIBA 11/2022
1	norflutoprazepamIBA 11/2022
1	ethylphenidateIBA 11/2022
1	etizolamIBA 11/2022
1	tianeptine (Stablon)IBA 11/2022
1	methyloneIBA 11/2022
1	mephedroneIBA 11/2022
1	furanyl fentanylIBA 11/2022
1	Cyproheptadine (Periactin)FDA Link 11/2022
1	Phenmetrazine (Preludin)FDA Link 11/2022
1	acrylfentanylIBA 11/2022
1	flubromazolamIBA 11/2022
1	clonazolamIBA 11/2022
1	flualprazolamIBA 11/2022
1	isotonitazeneIBA 11/2022
1	RimonabantIBA 10/2011
1	Neoprene (Polychloroprene)IBA 01/2011
1	OximesIBA 02/2009
1	AllergensIBA 01/2008
1	Terpenes (Terpenoids)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 05/2007
1	gamma-terpinene (beta-terpinene)IBA 06/2006
1	Monoterpenes (Monoterpenoids)IBA 06/2006
1	alpha phellandreneIBA 06/2006
1	beta-phellandreneIBA 06/2006